XML 17 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jul. 31, 2018
Apr. 30, 2018
Current Assets:    
Cash and cash equivalents $ 9,064 $ 9,716
Restricted cash 1,023 1,242
Receivables, less allowance: $332, $384, on each respective date 36,048 32,660
Inventories 15,006 17,662
Prepaid expenses and other current assets 3,387 2,224
Total Current Assets 64,528 63,504
Property, plant and equipment, at cost 55,258 54,648
Accumulated depreciation (40,616) (39,987)
Net Property, Plant and Equipment 14,642 14,661
Deferred income taxes 2,042 2,031
Other 3,714 4,162
Total Other Assets 5,756 6,193
Total Assets 84,926 84,358
Current Liabilities:    
Short-term borrowings and interest rate swaps 7,528 3,885
Current portion of long-term debt 1,167 1,167
Accounts payable 13,153 14,754
Employee compensation and amounts withheld 2,223 3,810
Deferred revenue 1,757 1,884
Other accrued expenses 3,068 2,062
Total Current Liabilities 28,896 27,562
Long-term debt 972 1,264
Accrued pension and deferred compensation costs 6,115 7,465
Income taxes payable 546 546
Total Liabilities 36,529 36,837
Commitments and Contingencies
Equity:    
Common Stock, $2.50 par value, Authorized - 5,000 shares; Issued - 2,744 shares; 2,736 shares; Outstanding - 2,741 shares; 2,733 shares, on each respective date 6,861 6,841
Additional paid-in-capital 3,092 3,006
Retained earnings 44,324 43,165
Accumulated other comprehensive loss (6,284) (5,900)
Common stock in treasury, at cost, 3 shares, on each date (53) (53)
Total Kewaunee Scientific Corporation Stockholders' Equity 47,940 47,059
Noncontrolling interest 457 462
Total Equity 48,397 47,521
Total Liabilities and Equity $ 84,926 $ 84,358